What Insulet’s EVOLUTION 2 data means for automated insulin delivery in type 2 diabetes
Insulet’s EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.
Can Medtronic and Abbott redefine insulin delivery with the Instinct-integrated MiniMed 780G?
Medtronic’s MiniMed 780G now ships in the U.S. with Abbott’s Instinct sensor. Explore how this launch could reshape CGM-insulin system competition.